0000899243-18-005140.txt : 20180222 0000899243-18-005140.hdr.sgml : 20180222 20180222181516 ACCESSION NUMBER: 0000899243-18-005140 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180220 FILED AS OF DATE: 20180222 DATE AS OF CHANGE: 20180222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kusserow Paul B. K. CENTRAL INDEX KEY: 0001456688 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 18633948 MAIL ADDRESS: STREET 1: 780 SAN YSIDRO ROAD CITY: SANTA BARBARA STATE: CA ZIP: 93108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-20 0 0000896262 AMEDISYS INC AMED 0001456688 Kusserow Paul B. K. 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 1 1 0 0 CEO and President Common Stock 2018-02-20 4 M 0 18750 0.00 A 97401 D Common Stock 2018-02-20 4 F 0 7393 56.87 D 90008 D Common Stock 452 I Through 401(k) Plan Performance-Based Restricted Shares 2018-02-20 4 M 0 18750 0.00 D Common Stock 18750 18750 D Stock Option (Right to Buy) 26.78 2018-02-20 4 A 0 62500 0.00 A 2018-02-20 2025-03-31 Common Stock 62500 187500 D The information in this report is based on a plan statement dated as of December 31, 2017. Each performance-based restricted share represents a contingent right to receive one share of unrestricted common stock. The performance-based restricted shares shall vest, if at all, based on the certification by the Comensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal years 2015 through 2018, respectively (subject to certain pro-rated vesting provisions as provided in the award agreement for the performance-based restricted shares). The performance criteria for fiscal year 2017 were met. The number of performance-based restricted shares listed in Table II, Column 9 represents the maximum number of shares of unrestricted common stock the Reporting Person would receive based on the satisfaction of all of the remaining pre-determined performance goals. On March 31, 2015, the reporting person was granted an option to purchase 250,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2017 were met, resulting in vesting of the option as to 62,500 shares. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2018-02-22